Research is continually evolving, focusing on understanding the molecular and genetic basis of gynecologic cancers. Advances in genomics, personalized medicine, and new drug developments are crucial. Clinical trials are exploring novel therapies, including CAR-T cell therapy and checkpoint inhibitors.
